Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study
Autor: | Landen, Jaren W., Andreasen, Niels, Cronenberger, Carol L., Schwartz, Pamela F., Börjesson-Hanson, Anne, Östlund, Henrik, Sattler, Catherine A., Binneman, Brendon, Bednar, Martin M. |
---|---|
Zdroj: | In Alzheimer's & Dementia: Translational Research & Clinical Interventions September 2017 3(3):393-401 |
Databáze: | ScienceDirect |
Externí odkaz: |